Allopurinol Tablets — Class II drug recall D-0583-2024
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2024-07-10, distributed in IL, MS, OH. Presence of foreign substance.
| Recall number | D-0583-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2024-06-07 |
| Classified | 2024-07-03 |
| Reported by FDA | 2024-07-10 |
| Terminated | 2025-12-22 |
| Distributed | IL, MS, OH |
| Quantity | 20,520 units |
| NDC | 55111-0729, 55111-0729-01, 55111-0729-10, 55111-0730, 55111-0730-01, 55111-0730-05 |
Product
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
Reason for recall
Presence of foreign substance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0583-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.